Month: August 2018
-
FDA Clears Magnetic Device for Obsessive Compulsive Disorder
A non-invasive device using magnetic waves that penetrate the brain to treat obsessive-compulsive disorder received authorization for sales in the U.S. from the Food and Drug Administration.
-
Can You Make More Money With Your Trades?
All you need to do is know where to invest, when to invest, and the things that can help you make more money.
-
In Case You Missed It …
A story last week in Science & Enterprise reports on a new NIH grant to the company Peptide Logic in San Diego, developing synthetic peptides that act on pain receptors outside the brain to avoid addiction.
-
Three Technologies That Make Your Recruitment Process Easier
Here are three examples of tech you can utilize if you’re recruiting for your business.
-
Infographic – 72,000 Opioid Overdose Deaths in 2017
A preliminary report from the Centers for Disease Control and Prevention shows that more than 72,000 deaths from opioid overdose were reported for 2017.
-
American Cities Leading The Way In Renewable Energy
There are a lot of cities around the country that are already moving toward renewables in a big way and they serve as an example of how we can all adopt clean energy in the future.
-
Nanoparticle Process Designed to Detect, Treat Oral Bacteria
A bioengineering lab devised a way to quickly detect and treat bacteria responsible for tooth decay with a combination of X-rays and a non-toxic compound in nanoscale particles.
-
Bread Wheat Genome Sequenced
An international collaboration published a complete, annotated genomic sequencing of wheat used in making bread, a widely grown staple crop and major source of nutrition worldwide.
-
Cosmetic Dentistry – A Worthy Investment In 2018?
The demand for cosmetic dentistry is still very much there, and the industry is experiencing different trends and developments in technology that is keeping the market growing.
-
Genomic Sequencing for Newborns Studied in Clinical Trial
A group of newborn infants with genetic disorders that went undetected in standard testing will receive genomic sequencing in a clinical study of its safety and feasibility.